ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 530,72
-1,03%
Dow Jones
39 164,06
0,09%
DAX
18 210,55
0,26%
Brent Oil
85,625
0,25%
Bitcoin
61 609,22
0,00%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Synlogic Inc (SYBX)

  7. Synlogic Inc (SYBX) Actualités

SYBX

Synlogic (SYBX)

Synlogic Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SYBX
DateHeureSourceTitreSymboleSociété
17/05/202401h44Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SYBXSynlogic Inc
14/05/202413h00GlobeNewswire Inc.Synlogic Reports First Quarter 2024 Financial ResultsNASDAQ:SYBXSynlogic Inc
14/05/202412h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SYBXSynlogic Inc
14/05/202412h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SYBXSynlogic Inc
19/03/202412h00GlobeNewswire Inc.Synlogic Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:SYBXSynlogic Inc
20/02/202423h05Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:SYBXSynlogic Inc
20/02/202418h15GlobeNewswire Inc.Synlogic Adopts Limited Duration Stockholders Rights PlanNASDAQ:SYBXSynlogic Inc
16/02/202422h54Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SYBXSynlogic Inc
16/02/202422h44Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:SYBXSynlogic Inc
14/02/202421h55Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SYBXSynlogic Inc
08/02/202422h15GlobeNewswire Inc.Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate UpdateNASDAQ:SYBXSynlogic Inc
02/02/202418h00GlobeNewswire Inc.Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical HomocystinuriaNASDAQ:SYBXSynlogic Inc
04/01/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SYBXSynlogic Inc
04/01/202413h00GlobeNewswire Inc.Synlogic Provides Corporate Update and Outlook for 2024NASDAQ:SYBXSynlogic Inc
27/12/202313h00GlobeNewswire Inc.Synlogic Announces Contract with the Air Force Research LabNASDAQ:SYBXSynlogic Inc
07/12/202313h00GlobeNewswire Inc.Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023NASDAQ:SYBXSynlogic Inc
09/11/202313h00GlobeNewswire Inc.Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:SYBXSynlogic Inc
07/11/202313h00GlobeNewswire Inc.Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche CollaborationNASDAQ:SYBXSynlogic Inc
03/10/202322h15GlobeNewswire Inc.Synlogic Announces Closing of $21.0 Million Underwritten Public OfferingNASDAQ:SYBXSynlogic Inc
02/10/202323h05Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SYBXSynlogic Inc
29/09/202313h00GlobeNewswire Inc.Synlogic Announces Pricing of $21.0 Million Underwritten Public OfferingNASDAQ:SYBXSynlogic Inc
29/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SYBXSynlogic Inc
29/09/202303h43Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:SYBXSynlogic Inc
28/09/202317h15GlobeNewswire Inc.Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature MetabolismNASDAQ:SYBXSynlogic Inc
28/09/202314h39Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SYBXSynlogic Inc
27/09/202318h30GlobeNewswire Inc.Synlogic Announces Reverse Stock SplitNASDAQ:SYBXSynlogic Inc
21/09/202313h00GlobeNewswire Inc.Synlogic to Participate in Chardan’s Genetic Medicines ConferenceNASDAQ:SYBXSynlogic Inc
19/09/202317h00GlobeNewswire Inc.Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100NASDAQ:SYBXSynlogic Inc
08/09/202322h06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SYBXSynlogic Inc
01/09/202314h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SYBXSynlogic Inc
 Showing the most relevant articles for your search:NASDAQ:SYBX

Dernières Valeurs Consultées

BIT
BUND3S
Solactive leveraged shor...
TG
A3K6QB
Duke Energy
BOV
ODPV3F
ODONTOPREV ON
BIT
P1Y2Q5
NLBNPIT1Y2Q5 20241220 18
DGFX
SOTAUSDT
SOTA PROTOCOL
BIT
UV4LJ2
UniCredit Bank
USOTC
TNLIF
Trainline (PK)
AQSE
XDNY.GB
Xtrackers IE Public
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés